In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
Discover how primary care providers, emergency clinicians, advanced care practitioners (ACPs), and other healthcare professionals can play a pivotal role in the early diagnosis and management of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.